The sodium iodide symporter (NIS) and potential regulators in normal, benign and malignant human breast tissue.
Curran, Catherine E
Morris, John C
Kerin, Michael J
Dwyer, Roisin M
AffiliationDivision of Surgery, School of Medicine, National University of Ireland Galway, Galway, Ireland.
Gene Expression Regulation, Neoplastic
Mammary Glands, Human
MetadataShow full item record
CitationThe sodium iodide symporter (NIS) and potential regulators in normal, benign and malignant human breast tissue. 2011, 6 (1):e16023 PLoS ONE
AbstractThe presence, relevance and regulation of the Sodium Iodide Symporter (NIS) in human mammary tissue remains poorly understood. This study aimed to quantify relative expression of NIS and putative regulators in human breast tissue, with relationships observed further investigated in vitro.
Human breast tissue specimens (malignant n = 75, normal n = 15, fibroadenoma n = 10) were analysed by RQ-PCR targeting NIS, receptors for retinoic acid (RARα, RARβ), oestrogen (ERα), thyroid hormones (THRα, THRβ), and also phosphoinositide-3-kinase (PI3K). Breast cancer cells were treated with Retinoic acid (ATRA), Estradiol and Thyroxine individually and in combination followed by analysis of changes in NIS expression.
The lowest levels of NIS were detected in normal tissue (Mean(SEM) 0.70(0.12) Log(10) Relative Quantity (RQ)) with significantly higher levels observed in fibroadenoma (1.69(0.21) Log(10)RQ, p<0.005) and malignant breast tissue (1.18(0.07) Log(10)RQ, p<0.05). Significant positive correlations were observed between human NIS and ERα (r = 0.22, p<0.05) and RARα (r = 0.29, p<0.005), with the strongest relationship observed between NIS and RARβ (r = 0.38, p<0.0001). An inverse relationship between NIS and PI3K expression was also observed (r = 0.21, p<0.05). In vitro, ATRA, Estradiol and Thyroxine individually stimulated significant increases in NIS expression (range 6-16 fold), while ATRA and Thyroxine combined caused the greatest increase (range 16-26 fold).
Although NIS expression is significantly higher in malignant compared to normal breast tissue, the highest level was detected in fibroadenoma. The data presented supports a role for retinoic acid and estradiol in mammary NIS regulation in vivo, and also highlights potential thyroidal regulation of mammary NIS mediated by thyroid hormones.
- Stimulation of retinoic acid-induced functional sodium iodide symporter (NIS) expression and cytotoxicity of ¹³¹I by carbamazepine in breast cancer cells.
- Authors: Willhauck MJ, O Kane DJ, Wunderlich N, Göke B, Spitzweg C
- Issue date: 2011 Jan
- Enhanced expression of adenovirus-mediated sodium iodide symporter gene in MCF-7 breast cancer cells with retinoic acid treatment.
- Authors: Lim SJ, Paeng JC, Kim SJ, Kim SY, Lee H, Moon DH
- Issue date: 2007 Mar
- MicroRNA-10a is reduced in breast cancer and regulated in part through retinoic acid.
- Authors: Khan S, Wall D, Curran C, Newell J, Kerin MJ, Dwyer RM
- Issue date: 2015 May 2
- Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone.
- Authors: Willhauck MJ, Sharif-Samani B, Senekowitsch-Schmidtke R, Wunderlich N, Göke B, Morris JC, Spitzweg C
- Issue date: 2008 May
- Reduction of stimulated sodium iodide symporter expression by estrogen receptor ligands in breast cancer cells.
- Authors: Cheong SJ, Jang D, Jeong HJ, Lim ST, Sohn MH, Katzenellenbogen JA, Kim DW
- Issue date: 2011 Feb